Cystic fibrosis in premature infants

K D Lu1, C Engmann, F Moya

  • 1Division of Pulmonary, Department of Pediatrics, John Hopkins University, Baltimore, MD, USA.

Insights

Cystic fibrosis (CF) is rarely diagnosed in premature infants. This study details the cases of three premature infants diagnosed with CF, highlighting clinical progression and treatment strategies.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Medical Genetics

Background:

  • Cystic fibrosis (CF) is a genetic disorder typically diagnosed in early childhood.
  • Diagnosis of CF in premature infants is uncommon, with limited case reports available.
  • Prematurity presents unique challenges for CF diagnosis and management.

Purpose of the Study:

  • To report the clinical course of three premature infants diagnosed with cystic fibrosis.
  • To review existing literature on CF in premature neonates.
  • To discuss current treatment considerations for this population.

Main Methods:

  • Case series describing three neonates diagnosed with CF.
  • Review of medical records and clinical outcomes.
  • Literature search for similar cases and treatment guidelines.

Main Results:

  • Three premature infants were diagnosed with cystic fibrosis in neonatal intensive care units.
  • Clinical presentations varied, necessitating early diagnostic interventions.
  • Successful management strategies were implemented based on established CF protocols.

Conclusions:

  • Cystic fibrosis can occur in premature infants, although rarely.
  • Early diagnosis and tailored management are crucial for improving outcomes.
  • Further research is needed to optimize care for CF in preterm neonates.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...